3,4-Ethylidenedioxyamphetamine

From WikiMD's Medical Encyclopedia

Revision as of 05:16, 3 March 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

3,4-Ethylidenedioxyamphetamine (EDA) is a synthetic compound belonging to the amphetamine class of psychoactive drugs. It is structurally related to other substituted amphetamines, such as 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA), which are known for their stimulant and empathogenic effects.

Chemical Structure and Properties[edit]

3,4-Ethylidenedioxyamphetamine is characterized by the presence of an ethylidene group attached to the 3,4-methylenedioxy ring of the amphetamine backbone. This modification distinguishes it from other related compounds and influences its pharmacological properties. The chemical formula for EDA is C12H15NO2.

Pharmacology[edit]

As a member of the substituted amphetamines, EDA is believed to act primarily as a serotonin and dopamine releasing agent. This mechanism of action is similar to that of other psychoactive amphetamines, which increase the levels of these neurotransmitters in the brain, leading to enhanced mood, increased energy, and altered perception.

Effects[edit]

The effects of 3,4-ethylidenedioxyamphetamine are not well-documented in scientific literature, but it is presumed to have stimulant and empathogenic properties similar to those of MDA and MDMA. Users may experience increased sociability, euphoria, and heightened sensory perception.

Legal Status[edit]

The legal status of EDA varies by country. In many jurisdictions, it is classified as a controlled substance due to its structural similarity to other regulated amphetamines. This classification restricts its manufacture, distribution, and possession.

Synthesis[edit]

The synthesis of 3,4-ethylidenedioxyamphetamine involves the chemical modification of the methylenedioxy ring structure. This process requires advanced knowledge of organic chemistry and access to specific reagents and equipment.

Safety and Toxicity[edit]

Due to the lack of comprehensive studies, the safety profile and toxicity of EDA are not well understood. As with other psychoactive substances, there is a potential for adverse effects, including neurotoxicity, cardiovascular issues, and psychological dependence.

Related Compounds[edit]

See Also[edit]

Related pages[edit]

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.